Informação sobre produto
Nome:
Nilestriol
Sinónimos:
- (16Alpha,17Beta)-3-(Cyclopentyloxy)-17-Ethynylestra-1,3,5(10)-Triene-16,17-Diol
- (16a,17b)-3-(Cyclopentyloxy)-17-ethynylestra-1,3,5(10)-triene-16,17-diol
- (16alpha,17beta)-3-(Cyclopentyloxy)-17-ethynylestra-1(10),2,4-triene-16,17-diol
- (16α,17α)-3-(Cyclopentyloxy)-19-norpregna-1,3,5(10)-trien-20-yne-16,17-diol
- 17a-Ethynylestra-1,3,5(10)-triene-3,16a,17b-triol 3-Cyclopentyl Ether
- 17alpha-Ethynylestra-1,3,5(10)-triene-3,16alpha,17beta-triol 3-cyclopentyl ether
- 17α-Ethynylestriol 3-cyclopentyl ether
- 19-Norpregna-1,3,5(10)-trien-20-yne-16,17-diol, 3-(cyclopentyloxy)-, (16α,17α)-
- 3-Cyclopentyloxy-19-nor-17α-pregna-1,3,5(10)-trien-20-yne-16α,17β-diol
- 39791-20-3
- Ver mais sinónimos
- EE<sub>3</sub>CPE
- Nylestriol
- WeiNiAn
Descrição:
Nilestriol is a synthetic estrogen that is used in the treatment of postmenopausal osteoporosis and other symptoms associated with menopause. It has been shown to inhibit the growth of cancer tissues by binding to hydroxyl groups. Nilestriol also binds to transcription-polymerase chain, which prevents RNA synthesis. This may lead to a decrease in levels of growth factor-β1, which is known to stimulate bone resorption. The long-term efficacy of nilestriol has been demonstrated in intrauterine studies with rats and monkeys. In these studies nilestriol was found to be non-toxic and effective at preventing uterine hyperplasia or endometrial cancer.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
380.52 g/mol
Fórmula:
C25H32O3
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
